Reductil sibutramine is categorized as an appetite suppressant weight loss drug. Reductil was approved by the FDA in 1997 as a prescription only weight loss drug. Since then Reductil sibutramine has helped number of obese people to effectively lose weight and lead a more healthy life.
Reductil sibutramine is recommended to patients who do not derive satisfactory weight loss results from regular means such as dieting and exercise. Though proved effective as a weight loss aid, Reductil sibutramine does not guarantee weight loss by its own. Reductil will only help people who are determined to lose weight and who use the drug in conjunction with a reduced calorie diet and exercise.
Sibutramine – the active ingredient in Reductil works on the neurotransmitters in the brain and dupes your brain to feel ‘full’ even when you have eaten less. Further, Reductil sibutramine also reduces craving in between meals so that you are not tempted to eat those high-calorie snacks. Thus by reducing your appetite, Reductil sibutramine controls the calorie in-take and thereby helps you to gradually loss weight.
Proper use of Reductil sibutramine
To achieve best weight loss results, one should make proper use of Reductil sibutramine. Given here is important information that will help you make proper use of Reductil sibutramine.
Always consult your doctor before using Reductil sibutramine and inform in detail about your general health conditions and medicines you may be taking. This will help your doctor determine the suitability of Reductil in your case and also determine the right Reductil sibutramine dosage for you.
The standard recommended dose of Reductil sibutramine is once daily, generally in the morning before your first meal. Reductil treatment is usually started with one 10mg tablet one day. However, your doctor may increase your dosage to 15mg depending on the effectiveness of the drug in your body and also on your tolerance to sibutramine. The dosage may also be reduced to 5mg if the 10mg treatment is not tolerated well by your body. In any case, do not alter the Reductil sibutramine dosage without first consulting your doctor.
Precautions to take before using Reductil sibutramine
Reductil sibutramine is a prescription only drug hence one should use proper precautions before using the drug for weight loss. This section offers you important information on precautions to take before using Reductil sibutramine weight loss drug.
While considering Reductil sibutramine treatment with your doctor either face-to-face or via online consultations always offer detailed information about your general health conditions and any type of prescription or OTC medicine that you may be taking. This will help your doctor to determine if Reductil will be appropriate for you and also determine the dosage.
- Do not use Reductil sibutramine if you have eating disorders, high blood pressure, and hardening of the arteries, have had a stroke.
- Do not use Reductil sibutramine if you have history of seizures, are taking another appetite suppressant, if you have taken anti-depressant monoamine oxidase inhibitor (MAO) inhibitor (eg, phenelzine) within the last 14 days.
- Do not use Reductil sibutramine if you have severe liver or kidney problems, hemophilia or other bleeding problems
- Do not use Reductil sibutramine if you are suffering from depression or if you have a history of depression.
- Do not use Reductil sibutramine if you are pregnant, breastfeeding or below 18 years of age.
- Caution is also advised in patients who have epilepsy or sleep apnea.
- Inform your doctor if you have glaucoma (an eye disease) or Parkinson’s disease.
- Inform your doctor if you have any allergies or if you have a known sensitivity to any of the ingredients of Reductil sibutramine.
- Inform your doctor immediately if you experience any bothersome Reductil side effects.
Tests on Reductil sibutramine
Reductil sibutramine is proven to be a safe and effective weight-loss drug in the numerous clinical trials that were conducted before the drug was approved for use. When used in conjunction with a reduced-calorie diet and proper physical activity, about 77 percent of patients achieved weight loss that benefited their health.
Eleven double-blind, placebo-controlled obesity trials were conducted on weight loss using Reductil. Study length varied from 12 to 52 weeks and doses ranged from 1 to 30 mg once daily. Weight was significantly lowered when doses varied from 5-20mg in Reductil treated patients as opposed to those treated with a placebo. In two 12-month studies, greatest level of weight loss was gained by 6 months and significant weight loss was upheld across the 12 months.